Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents

被引:105
作者
Zhang, Xiao-Min [1 ]
Qiu, Min [1 ]
Sun, Juan [1 ]
Zhang, Yan-Bin [1 ]
Yang, Yu-Shun [1 ]
Wang, Xiao-Liang [1 ]
Tang, Jian-Feng [1 ]
Zhu, Hai-Liang [1 ]
机构
[1] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
基金
美国国家科学基金会;
关键词
Synthesis; 1,3,4-Oxadiazole derivatives; Molecular docking; Antitumor activity; Telomerase inhibitor; ANTIINFLAMMATORY ACTIVITY; ANTITUMOR;
D O I
10.1016/j.bmc.2011.08.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In present study, a series of new 1,3,4-oxadiazole derivatives containing 1,4-benzodioxan moiety (6a-6s) as potential telomerase inhibitors were synthesized. The bioassay tests demonstrated that compounds 6k, 6l, 6m, 6n and 6s exhibited broad-spectrum antitumor activity with IC50 concentration range from 7.21 mu M to 25.87 mu M against the four cancer cell lines, HEPG2, HELA, SW1116 and BGC823. Moreover, all the title compounds were assayed for telomerase inhibition using the TRAP-PCR-ELISA assay. The results showed compound 6k possessed the most potent telomerase activity (IC50 = 1.27 +/- 0.05 mu M). Docking simulation was performed to position compound 6k into the active site of telomerase (3DU6) to determine the probable binding model. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6518 / 6524
页数:7
相关论文
共 29 条
  • [1] Abadi AH, 2003, CHEM PHARM BULL, V51, P838
  • [2] Flow injection analysis of doxazosin mesylate using UV-detection
    Altiokka, G
    Atkosar, Z
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 27 (05) : 841 - 844
  • [3] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [4] Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives
    Chen, Cai-Jun
    Song, Bao-An
    Yang, Song
    Xu, Guang-Fang
    Bhadury, Pinaki S.
    Jin, Lin-Hong
    Hu, De-Yu
    Li, Qian-Zhu
    Liu, Fang
    Xue, Wei
    Lu, Ping
    Chen, Zhuo
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (12) : 3981 - 3989
  • [5] Synthesis of new Δ2-isoxazoline derivatives and their pharmacological characterization as β-adrenergic receptor antagonists
    Conti, P
    Dallanoce, C
    De Amici, M
    De Micheli, C
    Klotz, KN
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (04) : 401 - 408
  • [6] Superior reactivity of thiosemicarbazides in the synthesis of 2-amino-1,3,4-oxadiazoles
    Dolman, Sarah J.
    Gosselin, Francis
    O'Shea, Paul D.
    Davies, Ian W.
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (25) : 9548 - 9551
  • [7] ESWAR N, 2007, CURR PROTOCOL PROTEI
  • [8] AUTOMATED DOCKING OF SUBSTRATES TO PROTEINS BY SIMULATED ANNEALING
    GOODSELL, DS
    OLSON, AJ
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1990, 8 (03): : 195 - 202
  • [9] Synthesis and biological activity of new anti-inflammatory compounds containing the 1,4-benzodioxine and/or pyrrole system
    Harrak, Y.
    Rosell, G.
    Daidone, G.
    Plescia, S.
    Schillaci, D.
    Pujol, M. D.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (14) : 4876 - 4890
  • [10] Synthesis and biological evaluation of novel 1β-methylcarbapenems having a new moiety at C-2
    Kang, YK
    Shin, KJ
    Yoo, KH
    Seo, KJ
    Park, SY
    Kim, DJ
    Park, SW
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) : 2385 - 2390